Gossamer Bio Reports on Shareholder Vote Matters

Ticker: GOSS · Form: 8-K · Filed: 2024-06-10T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting

TL;DR

Gossamer Bio held a shareholder vote on June 6th, filing the details today.

AI Summary

Gossamer Bio, Inc. filed an 8-K on June 10, 2024, reporting on matters submitted to a vote of security holders on June 6, 2024. The filing details the company's corporate structure, including its incorporation in Delaware and principal executive offices in San Diego, California.

Why It Matters

This filing indicates that Gossamer Bio held a shareholder vote, which is a key governance event for public companies and can signal important decisions or approvals.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote and does not contain information about significant financial distress or operational changes.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Gossamer Bio's security holders on June 6, 2024?

The filing states that the report is pursuant to "Submission of Matters to a Vote of Security Holders" but does not detail the specific proposals voted upon in the provided text.

When was the Form 8-K filed with the SEC?

The Form 8-K was filed on June 10, 2024.

What is Gossamer Bio, Inc.'s principal executive office address?

Gossamer Bio, Inc.'s principal executive offices are located at 3013 Science Park Road, San Diego, California, 92121.

Under which act is this Form 8-K filed?

This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is Gossamer Bio's state of incorporation?

Gossamer Bio, Inc. is incorporated in Delaware.

Filing Stats: 547 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-06-10 16:01:46

Key Financial Figures

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The following is a brief description of each matter voted upon at the Annual Meeting and the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable. 1. The election of two directors to serve as Class II directors for a three-year term to expire at the 2027 annual meeting of stockholders. The following two Class III directors were re-elected by the votes indicated: For Withheld Broker Non-Votes Skye Drynan 161,240,706 933,528 28,757,285 John Quisel, Ph.D., J.D. 161,260,707 913,527 28,757,285 2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The selection was ratified by the votes indicated: For Against Abstain Broker Non-Votes 189,741,141 1,157,767 32,611 — 3. The approval, on an advisory basis, of the compensation of the Company's named executive officers. The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated: For Against Abstain Broker Non-Votes 115,985,182 40,356,919 5,831,133 28,757,285 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. GOSSAMER BIO, INC. Date: June 10, 2024 By: /s/ Christian Waage Christian Waage Executive Vice President 2

View on Read The Filing